13F Holdings
中文EN

IRTC iRhythm Holdings, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1388658 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.6%
TTM net income YoY25.0%
TTM EPS YoY27.3%
Revenue 3-yr CAGR21.8%
Net income 3-yr CAGR—

Margins

Gross margin72.3%
Operating margin-5.7%
Net margin-4.5%
FCF margin0.9%
EBITDA margin-3.3%

Returns

ROE-25.8%
ROA-3.7%
ROIC (approx.)—
Asset turnover0.82x

Leverage & solvency

Liabilities / assets83.8%
Debt / equity0.00x
Current ratio3.57x
Interest coverage-3.71x

Cash quality & payout

Operating cash flow / net income-1.44x
Accruals ratio-9.0%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$747.14M$591.84M$492.68M$410.92M$322.82M
Cost of revenue$219.89M$184.31M$160.88M$129.29M$109.26M
Gross profit$527.25M$407.53M$331.81M$281.63M$213.57M
R&D expense$84.61M$71.46M$60.24M$46.61M$38.67M
SG&A expense$492.55M$418.56M$385.64M$322.20M$274.84M
Operating income-$57.41M-$115.50M-$125.16M-$113.78M-$99.94M
Interest expense$13.15M$12.82M$3.65M$4.14M$1.17M
Pretax income-$43.60M-$112.72M-$122.66M-$115.89M-$100.99M
Income tax$953,000$565,000$750,000$269,000$367,000
Net income-$44.55M-$113.29M-$123.41M-$116.16M-$101.36M
EBITDA-$36.71M-$94.81M-$108.86M-$100.38M-$90.14M
EPS (basic)-1.39-3.63-4.04-3.88-3.46
EPS (diluted)-1.39-3.63-4.04-3.88-3.46
Weighted avg. shares (diluted)32.00M31.20M30.53M29.92M29.33M
Balance sheet
Cash & equivalents$236.01M$427.95M$36.17M$78.83M$127.56M
Short-term investments$347.75M$115.96M$97.59M$134.31M$111.57M
Receivables$75.71M$79.94M$61.48M$49.92M$46.43M
Inventory$21.63M$14.04M$13.97M$15.15M$10.27M
Current assets$702.76M$645.82M$230.81M$288.77M$305.52M
PP&E, net$151.60M$125.09M$104.11M$75.67M$55.94M
Goodwill$862,000$862,000$862,000$862,000$862,000
Total assets$1.02B$931.45M$433.14M$448.22M$462.97M
Current liabilities$151.89M$110.92M$107.37M$89.10M$87.85M
Short-term debt———$0$11.67M
Long-term debt——$34.95M$34.94M$9.69M
Total debt——$34.95M$34.94M$21.36M
Total liabilities$867.30M$840.54M$223.05M$208.41M$183.45M
Shareholders' equity$152.75M$90.91M$210.10M$239.81M$279.51M
Net debt——-$1.22M-$43.90M-$106.20M
Shares outstanding32.30M31.39M30.95M30.19M29.49M
Cash flow statement
Operating cash flow$80.86M$3.39M-$50.10M-$23.01M-$37.75M
Capital expenditure$46.34M$33.94M$40.42M$29.83M$28.07M
Free cash flow$34.52M-$30.55M-$90.53M-$52.84M-$65.82M
Investing cash flow-$277.06M-$122.98M-$1.21M-$52.43M$105.26M
Financing cash flow$12.61M$511.38M$8.82M$26.72M-$28.58M
Depreciation & amortization$20.70M$20.70M$16.30M$13.40M$9.80M
Stock-based compensation$88.28M$75.98M$77.20M$57.74M$54.53M
Share buybacks$0$25.00M$0$0—

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.